サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1339175

心内膜生検市場、シェア、規模、動向、産業分析レポート：製品別；チップ別；最終用途別；地域別；セグメント別予測、2023-2032年

Endomyocardial Biopsy Market Share, Size, Trends, Industry Analysis Report, By Product (Forceps, Accessories); By Tip (Straight, Maxi-curved, Pre-curved); By End-use (Hospitals, Ambulatory Surgical Centers); By Region, & Segment Forecasts, 2023-2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 114 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
心内膜生検市場、シェア、規模、動向、産業分析レポート：製品別；チップ別；最終用途別；地域別；セグメント別予測、2023-2032年
出版日: 2023年07月23日
発行: Polaris Market Research
ページ情報: 英文 114 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、心内膜生検の世界市場規模は2032年までに5億9,952万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

心臓移植の増加に伴い、拒絶反応の可能性をモニタリングして検出する必要性も高まっています。心内膜生検は心臓拒絶反応の診断に重要な役割を果たし、移植後に実施されることが多いです。したがって、心臓移植の増加は間接的に市場の成長につながります。

冠動脈疾患、心不全、不整脈などの心血管疾患の有病率の増加は、市場成長の主な促進要因です。また、痛みの軽減、回復の早さ、入院期間の短縮などの利点を提供する低侵襲手術に対する需要の高まりも、市場の成長に寄与しています。加えて、冠動脈インターベンション治療に対する有利な償還政策が、移植片の機能を評価し、心臓移植患者の拒絶反応を検出するための診断ツールとして、心内膜生検を実施するよう医療提供者を奨励しています。

新興国は心内膜生検市場の成長と拡大の大きな機会を提供しています。これらの経済圏におけるヘルスケア支出の増加と医療インフラへの投資が、心内膜生検手技の需要を促進すると予想されます。多国籍企業は、自社製品を導入して市場の大部分を獲得するために、これらの地域への投資を増やしています。この動向は予測期間中も続くと予想され、新興国における心内膜生検市場の成長を牽引します。

市場の成長は、米国FDA、カナダ保健省、EMA、COFEPRIS、MHRA、CDSCOなどのさまざまな規制機関がこの分野の研究開発を支援するイニシアチブをとっていることによってさらに支えられています。例えば、2020年3月、米国FDAはIVERIC Bio社のZimuraをAMDに続発する地理的萎縮症（GA）患者の治療薬としてFast Track指定しました。これはペグ化RNAアプタマーで、合成され、硝子体内注射によって投与されます。AMD発症の原因とされるC5因子を阻害することにより作用します。

心内膜生検市場レポートハイライト

より優れたグリップと機能を備えた革新的な鉗子の開発により、鉗子分野が市場を独占

先端ストレート型が市場シェア上位を占める。これは、先端がストレートであるため、生検手技中の組織へのダメージが少ないことによる。

ホスピタリティ部門が最大のシェアを獲得しました。ホスピタリティのある病院は設備が整っており、専属の医師や看護師がいます。

アジア太平洋地域は、患者数が多く、未開拓人口が多いこと、政府の研究政策が良好であることから、高い成長率を記録すると予測されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の心内膜生検市場に関する洞察

  • 心内膜生検市場- 最終用途のスナップショット
  • 心内膜生検市場力学
    • 促進要因と機会
      • 心血管障害（CVD）の有病率の増加
      • 新興経済諸国における未開発の機会。
    • 抑制要因と課題
      • 心内膜生検に関連する合併症
  • PESTEL分析
  • 心内膜生検市場のエンドユース動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の心内膜生検市場、製品別

  • 主な調査結果
  • イントロダクション
  • 鉗子
  • アクセサリー

第6章 チップ別の世界の心内膜生検市場

  • 主な調査結果
  • イントロダクション
  • マキシカーブ
  • 真っ直ぐ
  • プレカーブ
  • その他

第7章 世界の心内膜生検市場、エンドユース別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 外来手術センター
  • その他

第8章 世界の心内膜生検市場、地域

  • 主な調査結果
  • イントロダクション
    • 心内膜生検市場評価、地域、2019-2032年
  • 心内膜生検市場-北米
    • 北米：心内膜生検市場、製品別、2019-2032年
    • 北米：心内膜生検市場、エンドユース別、2019-2032年
    • 北米：心内膜生検市場、チップ別、2019-2032年
    • 心内膜生検市場-米国
    • 心内膜生検市場- カナダ
  • 心内膜生検市場- 欧州
    • 欧州：心内膜生検市場、製品別、2019～2032年
    • 欧州：心内膜生検市場、エンドユース別、2019～2032年
    • 欧州：心内膜生検市場、チップ別、2019～2032年
    • 心内膜生検市場- 英国
    • 心内膜生検市場- フランス
    • 心内膜生検市場- ドイツ
    • 心内膜生検市場- イタリア
    • 心内膜生検市場- スペイン
    • 心内膜生検市場- オランダ
    • 心内膜生検市場- ロシア
  • 心内膜生検市場- アジア太平洋
    • アジア太平洋：心内膜生検市場、製品別、2019～2032年
    • アジア太平洋：心内膜生検市場、エンドユース別、2019～2032年
    • アジア太平洋：心内膜生検市場、ヒント別、2019～2032年
    • 心内膜生検市場- 中国
    • 心内膜生検市場- インド
    • 心内膜生検市場- マレーシア
    • 心内膜生検市場- 日本
    • 心内膜生検市場- インドネシア
    • 心内膜生検市場- 韓国
  • 心内膜生検市場-中東およびアフリカ
    • 中東およびアフリカ：心内膜生検市場、製品別、2019～2032年
    • 中東およびアフリカ：心内膜生検市場、エンドユース別、2019～2032年
    • 中東およびアフリカ：心内膜生検市場、チップ別、2019～2032年
    • 心内膜生検市場- サウジアラビア
    • 心内膜生検市場- アラブ首長国連邦
    • 心内膜生検市場- イスラエル
    • 心内膜生検市場- 南アフリカ
  • 心内膜生検市場-ラテンアメリカ
    • ラテンアメリカ：心内膜生検市場、製品別、2019-2032年
    • ラテンアメリカ：心内膜生検市場、エンドユース別、2019-2032
    • ラテンアメリカ：心内膜生検市場、チップ別、2019-2032年
    • 心内膜生検市場- メキシコ
    • 心内膜生検市場- ブラジル
    • 心内膜生検市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Argon Medical
  • Cordis, Mermaid Medical
  • Terumo Corp
  • Scholten Surgicals
  • Changzhou Lookmed
  • Fehling Instruments
図表

List of Tables

  • Table 1 Global Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 2 Global Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 3 Global Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 4 Endomyocardial Biopsy Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 6 North America: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 7 North America: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 8 U.S.: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 9 U.S.: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 10 U.S.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 11 Canada: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 12 Canada: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 13 Canada: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 14 Europe: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 15 Europe: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 16 Europe: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 17 UK: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 18 UK: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 19 UK: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 20 France: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 21 France: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 22 France: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 23 Germany: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 24 Germany: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 25 Germany: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 26 Italy: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 27 Italy: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 28 Italy: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 29 Spain: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 30 Spain: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 31 Spain: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 32 Netherlands: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 33 Netherlands: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 34 Netherlands: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 35 Russia: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 36 Russia: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 37 Russia: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 41 China: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 42 China: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 43 China: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 44 India: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 45 India: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 46 India: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 47 Malaysia: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 48 Malaysia: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 49 Malaysia: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 50 Japan: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 51 Japan: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 52 Japan: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 53 Indonesia: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 54 Indonesia: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 55 Indonesia: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 56 South Korea: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 57 South Korea: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 58 South Korea: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 65 UAE: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 66 UAE: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 67 UAE: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 68 Israel: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 69 Israel: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 70 Israel: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 71 South Africa: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 72 South Africa: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 73 South Africa: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 74 Latin America: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 75 Latin America: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 76 Latin America: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 77 Mexico: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 78 Mexico: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 79 Mexico: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 80 Brazil: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 81 Brazil: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 82 Brazil: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • Table 83 Argentina: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • Table 84 Argentina: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • Table 85 Argentina: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Endomyocardial Biopsy Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Tip
  • Figure 7. Global Endomyocardial Biopsy Market, by Tip, 2022 & 2032 (USD Million)
  • Figure 8. Market by Product
  • Figure 9. Global Endomyocardial Biopsy Market, by Product, 2022 & 2032 (USD Million)
  • Figure 10. Market by End-Use
  • Figure 11. Global Endomyocardial Biopsy Market, by End-Use, 2022 & 2032 (USD Million)
  • Figure 12. Endomyocardial Biopsy Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Endomyocardial Biopsy Market
目次
Product Code: PM3555

The global endomyocardial biopsy market size is expected to reach USD 599.52 million by 2032, according to a new study by Polaris Market Research. The report "Endomyocardial Biopsy Market Share, Size, Trends, Industry Analysis Report, By Product (Forceps, Accessories); By Tip (Straight, Maxi-curved, Pre-curved); By End-use (Hospitals, Ambulatory Surgical Centers); By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

With the increasing number of heart transplants, there is also a rising need for monitoring and detection of possible rejection. Endomyocardial biopsy procedures play a crucial role in diagnosing heart rejection and are often performed in the post-transplant period. Therefore, the increasing number of heart transplants would indirectly lead to the growth of the market.

Increasing prevalence of cardiovascular disorders, such as coronary artery disease, heart failure, and arrhythmias, is a major driving factor for the growth of the market. The rising demand for the minimally invasive surgeries, which offer benefits such as reduced pain, faster recovery, & shorter hospital stays, has also contributed to the growth of the market. In addition, favorable reimbursement policies for coronary intervention procedures have encouraged healthcare providers to perform endomyocardial biopsies as a diagnostic tool for evaluating the graft function and detecting rejection in heart transplant patients.

Emerging economies present a huge opportunity for growth and expansion of the endomyocardial biopsy market. The increasing healthcare spending and investments in the healthcare infrastructure in these economies are expected to drive the demand for endomyocardial biopsy procedures. Multinational companies are increasingly investing in these regions to introduce their products and capture a significant portion of the market. This trend is expected to continue during the forecast period, driving the growth of the endomyocardial biopsy market in the emerging economies.

Market growth is further supported by various regulatory agencies such as the U.S. FDA, Health Canada, EMA, COFEPRIS, MHRA, & CDSCO, which have taken initiatives to support the research and development in this field. For example, in March 2020, the U.S. FDA granted Fast Track designation to IVERIC Bio's Zimura for the treatment of patients with geographic atrophy (GA) secondary to AMD. It is a pegylated RNA aptamer, which is synthesized & administered by the intra-vitreal injection. It works by the inhibition of factor C5, considered responsible for onset of AMD.

Endomyocardial Biopsy Market Report Highlights

Forceps segment dominated the market, owing to the development of innovative forceps with better grip and features

Straight tip segment accounted for the larger market share. This is due to the fact straight tips causes less damage to the tissues during biopsy procedures

Hospitals segment garnered the largest share. Hospitals are better equipped equipment and have dedicated doctors and nurses

Asia Pacific is projected to register a higher growth rate, owing to the presence of large patient pool, huge untapped population, and favorable government policies for research.

The global players include: Argon Medical, Cordis, Mermaid Medical, Terumo Corp., Scholten Surgicals, Changzhou Lookmed, and Fehling Instruments.

Polaris Market Research has segmented the endomyocardial biopsy market report based on product, tip, end use, and region:

Endomyocardial Biopsy, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Forceps
  • Accessories

Endomyocardial Biopsy, Tip Outlook (Revenue - USD Million, 2019 - 2032)

  • Maxi-curved
  • Straight
  • Pre-curved
  • Others

Endomyocardial Biopsy, End Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Endomyocardial Biopsy, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data End-Uses
    • 3.2.1. Primary End-Uses
    • 3.2.2. Secondary End-Uses

4. Global Endomyocardial Biopsy Market Insights

  • 4.1. Endomyocardial Biopsy Market - End-Use Snapshot
  • 4.2. Endomyocardial Biopsy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of cardiovascular disorders (CVDs)
      • 4.2.1.2. Untapped opportunities in developing economies.
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complications associated with endomyocardial biopsy
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Endomyocardial Biopsy Market End-Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Endomyocardial Biopsy Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
  • 5.3. Forceps
    • 5.3.1. Global Endomyocardial Biopsy Market, by Forceps, by Region, 2019-2032 (USD Million)
  • 5.4. Accessories
    • 5.4.1. Global Endomyocardial Biopsy Market, by Accessories, by Region, 2019-2032 (USD Million)

6. Global Endomyocardial Biopsy Market, by Tip

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • 6.3. Maxi-curved
    • 6.3.1. Global Endomyocardial Biopsy Market, by Maxi-curved, by Region, 2019-2032 (USD Million)
  • 6.4. Straight
    • 6.4.1. Global Endomyocardial Biopsy Market, by Straight, by Region, 2019-2032 (USD Million)
  • 6.5. Pre-curved
    • 6.5.1. Global Endomyocardial Biopsy Market, by Pre-curved, by Region, 2019-2032 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Endomyocardial Biopsy Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Endomyocardial Biopsy Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Global Endomyocardial Biopsy Market, by Hospitals, By Region, 2019-2032 (USD Million)
  • 7.4. Ambulatory Surgical Centers
    • 7.4.1. Global Endomyocardial Biopsy Market, by Ambulatory Surgical Centers, By Region, 2019-2032 (USD Million)
  • 7.4. Others
    • 7.4.1. Global Endomyocardial Biopsy Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Endomyocardial Biopsy Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Endomyocardial Biopsy Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Endomyocardial Biopsy Market - North America
    • 8.3.1. North America: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
    • 8.3.2. North America: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
    • 8.3.3. North America: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.3.4. Endomyocardial Biopsy Market - U.S.
      • 8.3.4.1. U.S.: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.3.5. Endomyocardial Biopsy Market - Canada
      • 8.3.5.1. Canada: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • 8.4. Endomyocardial Biopsy Market - Europe
    • 8.4.1. Europe: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.3. Europe: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.4.4. Endomyocardial Biopsy Market - UK
      • 8.4.4.1. UK: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.4.5. Endomyocardial Biopsy Market - France
      • 8.4.5.1. France: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.5.3. France: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.4.6. Endomyocardial Biopsy Market - Germany
      • 8.4.6.1. Germany: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.4.7. Endomyocardial Biopsy Market - Italy
      • 8.4.7.1. Italy: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.4.8. Endomyocardial Biopsy Market - Spain
      • 8.4.8.1. Spain: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.4.9. Endomyocardial Biopsy Market - Netherlands
      • 8.4.9.1. Netherlands: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.4.10. Endomyocardial Biopsy Market - Russia
      • 8.4.10.1. Russia: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • 8.5. Endomyocardial Biopsy Market - Asia Pacific
    • 8.5.1. Asia Pacific: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.5.4. Endomyocardial Biopsy Market - China
      • 8.5.4.1. China: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.4.3. China: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.5.5. Endomyocardial Biopsy Market - India
      • 8.5.5.1. India: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.5.3. India: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.5.6. Endomyocardial Biopsy Market - Malaysia
      • 8.5.6.1. Malaysia: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.5.7. Endomyocardial Biopsy Market - Japan
      • 8.5.7.1. Japan: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.5.8. Endomyocardial Biopsy Market - Indonesia
      • 8.5.8.1. Indonesia: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.5.9. Endomyocardial Biopsy Market - South Korea
      • 8.5.9.1. South Korea: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • 8.6. Endomyocardial Biopsy Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.6.4. Endomyocardial Biopsy Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.6.5. Endomyocardial Biopsy Market - UAE
      • 8.6.5.1. UAE: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.6.6. Endomyocardial Biopsy Market - Israel
      • 8.6.6.1. Israel: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.6.7. Endomyocardial Biopsy Market - South Africa
      • 8.6.7.1. South Africa: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
  • 8.7. Endomyocardial Biopsy Market - Latin America
    • 8.7.1. Latin America: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.7.4. Endomyocardial Biopsy Market - Mexico
      • 8.7.4.1. Mexico: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.7.5. Endomyocardial Biopsy Market - Brazil
      • 8.7.5.1. Brazil: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)
    • 8.7.6. Endomyocardial Biopsy Market - Argentina
      • 8.7.6.1. Argentina: Endomyocardial Biopsy Market, by Product, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Endomyocardial Biopsy Market, by End-Use, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Endomyocardial Biopsy Market, by Tip, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Argon Medical
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Cordis, Mermaid Medical
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Terumo Corp
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Scholten Surgicals
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Changzhou Lookmed
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Fehling Instruments
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development